HemaCell is based in Stanford, California. It has raised $57M in total funding. Latest round: Series B.
HemaCell is based in Stanford, California. HemaCell has raised $57M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2026. The round record for HemaCell runs through 2026; nothing later has been disclosed. Investors on record include Shenzhen Capital Group (SCGC), Hebei Industrial Investment Fund, CDH Investments, Wedo Venture Capital, Lucion Venture Capital, Founder H Fund and 6 others. 12 distinct backers are named across the disclosed rounds.
Every HemaCell figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Stanford at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026